ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.84 CNY | +0.96% |
|
+5.32% | +7.98% |
| Apr. 24 | Huahai Pharmaceutical Gets Approval to Market Busulfan Injection | MT |
| Apr. 19 | Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023. | CI |
Evolution of the average Target Price on Zhejiang Huahai Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
588b9447a255c4bc008ebca4c.-FeaZLIg_ABwHCxwUT-Fl7RjQuFYfinvOdRG-Vl8ZGw.vDHKMvdlk3Y9RGpEfErgp8A3JY5oR0O2VKcOqxsEF1rAAqwB1GW3Sjd3Qw~407756c12d4b98f9199176f6bd20a5f6
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
15.84
CNY
Average target price
16.37
CNY
Spread / Average Target
+3.32%
High Price Target
19.5
CNY
Spread / Highest target
+23.11%
Low Price Target
14
CNY
Spread / Lowest Target
-11.62%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- 600521 Stock
- Consensus Zhejiang Huahai Pharmaceutical Co., Ltd.
